Paper41333481
Mechanisms of immunotherapy in cutaneous squamous cell carcinoma in the tumor microenvironment.
Dong Q and 3 others. Front Immunol, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Mechanisms of immunotherapy in cutaneous squamous cell carcinoma in the tumor microenvironment. Papers, record 41333481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41333481
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mechanisms of immunotherapy in cutaneous squamous cell carcinoma in the tumor microenvironment.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tumor Microenvironment | Major topic |
| Skin Neoplasms | Major topic |
| Immunotherapy | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Humans | |
| Immune Checkpoint Inhibitors | |
| Animals |
Source PubMed
References140
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32849616 | Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment. | Front Immunol | 2020 | https://conductscience.org/library/papers/32849616 | PubMed |
| 2 | 26811634 | Biomarkers of skin toxicity induced by anti-epidermal growth factor receptor antibody treatment in colorectal cancer. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/26811634 | PubMed |
| 3 | 22566933 | Molecular mechanisms of treg-mediated T cell suppression. | Front Immunol | 2012 | https://conductscience.org/library/papers/22566933 | PubMed |
| 4 | 37686588 | Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37686588 | PubMed |
| 5 | 36148955 | Single-cell analysis reveals that cancer-associated fibroblasts stimulate oral squamous cell carcinoma invasion via the TGF-β/Smad pathway. | Acta Biochim Biophys Sin (Shanghai) | 2022 | https://conductscience.org/library/papers/36148955 | PubMed |
| 6 | 31091995 | Survival Outcomes for Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck. | Ann Otol Rhinol Laryngol | 2019 | https://conductscience.org/library/papers/31091995 | PubMed |
| 7 | 33989559 | Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial. | Lancet Oncol | 2021 | https://conductscience.org/library/papers/33989559 | PubMed |
| 8 | 39912096 | Pembrolizumab for the Treatment of Locally Advanced Cutaneous Squamous Cell Carcinoma: Patient Selection and Special Considerations. | Cancer Manag Res | 2025 | https://conductscience.org/library/papers/39912096 | PubMed |
| 9 | 26946344 | Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. | Gastroenterology | 2016 | https://conductscience.org/library/papers/26946344 | PubMed |
| 10 | 38280470 | VEGF signaling: Role in angiogenesis and beyond. | Biochim Biophys Acta Rev Cancer | 2024 | https://conductscience.org/library/papers/38280470 | PubMed |
| 11 | 39663166 | Prediction of relative survival trends in patients with cutaneous squamous cell carcinoma using a model-based period analysis: a retrospective analysis of the surveillance, epidemiology, and end results database. | BMJ Open | 2024 | https://conductscience.org/library/papers/39663166 | PubMed |
| 12 | 28813164 | Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/28813164 | PubMed |
| 13 | 26216631 | Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment. | Adv Cancer Res | 2015 | https://conductscience.org/library/papers/26216631 | PubMed |
| 14 | 34375482 | Tumor-associated macrophage-derived transforming growth factor-β promotes colorectal cancer progression through HIF1-TRIB3 signaling. | Cancer Sci | 2021 | https://conductscience.org/library/papers/34375482 | PubMed |
| 15 | 34224993 | TIM-3: An update on immunotherapy. | Int Immunopharmacol | 2021 | https://conductscience.org/library/papers/34224993 | PubMed |
| 16 | 37492477 | Association between pH regulation of the tumor microenvironment and immunological state. | Front Oncol | 2023 | https://conductscience.org/library/papers/37492477 | PubMed |
| 17 | 32158481 | Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment. | Drugs Context | 2019 | https://conductscience.org/library/papers/32158481 | PubMed |
| 18 | 35406451 | Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35406451 | PubMed |
| 19 | 34409048 | New Isotopes for the Treatment of Pancreatic Cancer in Collaboration With CERN: A Mini Review. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34409048 | PubMed |
| 20 | 37146405 | Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease. | EBioMedicine | 2023 | https://conductscience.org/library/papers/37146405 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42795027 | Treatment Strategies for Advanced Cutaneous Squamous Cell Carcinoma Following Anti-PD-1 Immunotherapy Failure: A Systematic Review of the Literature and Ongoing Trials. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42795027 | PubMed |
| 42609920 | Single-cell transcriptomic analysis of cutaneous squamous cell carcinoma identifies an NR1H3-associated angiogenic macrophage state. | Front Immunol | 2026 | https://conductscience.org/library/papers/42609920 | PubMed |
| 42088400 | Recent Advances in Novel Drug Delivery Systems for the Management of Cutaneous Squamous Cell Carcinoma. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42088400 | PubMed |
| 41514652 | Spontaneous cSCC Murine Model Shows Limited Response to PD-1 Blockade and Radiation Combination Therapy. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41514652 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41333481
GET https://conductscience.org/api/papers/v1/41333481/references?page=2